Domain Associates is a private equity and venture capital firm that focuses on funding startups in the field of life sciences. The firm was founded in 1985 by Jesse I. Treu. Jim Blair has joined the firm since its inception and has remained as one of the firm’s partner as of February 2019. The firm’s current headquarters is located in New Jersey, but it also has offices in San Diego and Philadelphia.
In the past, the Domain Associates has invested in companies offering their business services in these fields: pharmaceuticals, diagnostics, and medical devices. The firm has also financed companies seeking various stages of funding: from incubation-stage startups to companies already at the stage of emerging growth
As of February 2019, the firm has raised more than $2.8 billion throughout its funding series. Its last funding series was launched in December 2016, and it managed to obtain $163.6 million. In December 2003 and April 2009 respectively, the firm succeeded in acquiring $500 million for each funding series.
A company focused on development of products to treat central nervous system disorders, pain and rare diseases
Oraya Therapeutics is a biotechnology company developing non-invasive therapies for eye diseases that is headquartered in San Francisco, California and was founded in 2007 by Michael Gertner.
A company developing therapies for inflammation and neurological diseases
A diagnostics company offering genomic tests services
A diagnostics company providing real-time biopsy material to guide personalized medicine for cancer patients
A compant developing nanoscale imaging and analytic platforms to analyze DNA
A life science devices company focused on the discovery and development of protein biomarkers as diagnostic tests
A pharmaceutical company engaged in the discovery, development and commercializtion of antibacterials for the treatment of infections
A biotechnology company focused on the discovery and development of protein therapeutics
A company focused on the discovery and development of treatments for rare inherited diseases.
Alimera Sciences is an Alpharetta, Georgia-based company.
A company focused on the development proteomics
A molecular diagnostics company that develops testing for infecctious diseases
A pharmacological company that develops PARP inhibitors as cancer therapies
A company that designs and manufactures implantable products to treat presbyopia
A company developing therapeutics for diseases
A company focused on discovery and development of protein biologics for human therapeutics to treat rare diseases
A biopharmaceutical company focused on developing therapeutics for the treatment of liver disease, inflammation, fibrosis and HIV
Esperion Therapeutics is an Ann Arbor, Michigan-based company.
A biopharmaceutical company focused on developing treatments for inner and middle ear diseases
A biopharmaceutical company developing therapies for the treatment of cancer
A company developing antithrombotic drug systems to treat acute and sub-acute cardiovascular and other indications
A biopharmaceutical company developing ganaxolone for the treatment of drug-resistant seizures and neuropsychiatric disorders
Associated investment funds
Jesse I. Treu
Documentaries, videos and podcasts